This article is more than 5 years old. Information may no longer be current.

Trials leader receives award

Issue: September 25, 2012

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Susan Goodin, PharmD, FCCP, BCOP

Susan Goodin, PharmD, FCCP, BCOP, associate director of clinical trials and therapeutics at The Cancer Institute of New Jersey, received the 2012 Award of Excellence from the Hematology/Oncology Pharmacy Association.

The award recognizes Goodin’s significant and sustained contributions to hematology/oncology pharmacy, and for providing leadership in supporting or improving this area.

Goodin, a professor of medicine at UMDNJ-Robert Wood Johnson Medical School, leads the Cancer Institute of New Jersey’s clinical trials program. She also serves as director of the institute’s division of pharmaceutical sciences. In that role, she oversees the pharmacy team that provides medications for patients and educates those patients about usage, pain management and other related issues.

An active researcher, Goodin also studies investigational drugs via clinical trials and promotes the importance of such study as a way to help researchers unlock the mysteries of cancer.